Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
cancer - search results
If you're not happy with the results, please do another search
Neuromyelitis optica (NMO) – on the path to a cure
Dr. Ludivine Herman, Project Leader at immunotherapy specialist Imcyse, walks us through Neuoromyelitis optica facts & trends, the challenges of current therapies and the potential of immunotherapies.
Impact of maternal and early-life high-fat diets on children and adults
How does eating a high-fat diet during pregnancy or in early life affect your health? Researchers tested on rat offspring to study how diet impacts future preferences.
The relationship between alcohol consumption and chronic pain
New research reveals how both alcohol consumption and withdrawal have the potential to result in hypersensitivity and increased chronic pain.
Biomedical research and innovation, including autism
Open Access Government provides a short introduction to biomedical research and innovation in the UK, including autism.
Care policy in Europe under the spotlight
Open Access Government places care policy in Europe under the spotlight, including support for caregivers and those with rare diseases or cancer.
Supporting talent at the National Research Foundation of Korea (NRF)
Open Access Government unpacks some of the research support that takes place in the National Research Foundation of Korea.
Targeting the Cannabinoid Type-2 Receptor for Novel Anto-inflammatory Therapeutics
Type-2 cannabinoid receptor (CB2R) is a G-protein-coupled receptor (GPCR) and an essential element of the endocannabinoid system (ECS) [1].
Plans to make a ‘single source’ of data between NHS and private healthcare
NHS England has plans to merge data with private healthcare institutions to process and share information on healthcare activity.
Why government agencies need decision intelligence to reach data-driven objectives
Decision Intelligence helps government agencies to unify their data and improve mission-critical decision-making to drive better services.
PFAS: The “New” Forever Chemicals
The term “forever chemicals” has become part of the lexicon in lay science. This reflects the growing evidence that exposure to perfluoroalkyl substances (PFAS), a class of synthetic chemicals widely detected in our natural environment, our foods, and our bodies, is associated with adverse human health effects and harm...
Exploring current and future therapies for childhood astrocytoma
Here, Doctor Peter J Houghton explains current therapies for childhood brain cancer what needs to change to ensure better outcomes for children diagnosed with astrocytoma in the future.
Charities call for urgent regulation on supermarket sugar sales
Research has revealed that nine out of ten UK supermarkets lack any policies to measure total supermarket sugar sales across all products and set reduction targets.
Using of opioids for chronic pain: Controversies, guidelines, research needs
First in a series of five articles, Norm Buckley and Jason Busse explore the trials and tribulations associated with using opioids for chronic pain, particularly in Canada.
Acute care hospital reform in Japan: Outcomes in quality and market competition
This paper describes why the fee system for acute care hospital reform in Japan is beginning to show results.
The link between gene expression and machine learning
Professor Y-h. Taguchi uses tensor decomposition to identify genes associated with altered gene expression caused by drug treatment.
Exploring hexacorallian models to aid corals affected by climate change
In this interview, Benyamin Rosental, PhD, from the Shraga Segal Department of Microbiology, Immunology, and Genetics, looks toward hexacorallian models to transplant stem cells to corals affected by global warming.
Why do the effects of an anti-ageing drug differ with gender?
The effect of the anti-ageing drug rapamycin differs in male and female fruit flies, find researchers, who seek to understand how sex influences the development of age-related disease.
HIV therapeutic targets: Basic virology to the discovery of antiretroviral drugs
Do we need new antiretroviral drugs to treat HIV infection, and if so, what are the promising targets? Dr Eric O. Freed, Director of the HIV Dynamics and Replication Program at the National Cancer Institute in Frederick, Maryland, discusses these questions.
Making the UK a lung research superpower will save lives
Dr Samantha Walker, Director of Research and Innovation at Asthma + Lung UK, explains why prioritising lung research is the best way to improve the nation’s health.
A digital healthcare system is not beyond the realms of possibility
In order to establish an effective digital healthcare system, we need to build trust with privacy first, argues Nigel Jones, co-founder of the Privacy Compliance Hub.
